Assessment of educational intervention impact on improving pharmacovigilance knowledge among health care providers: A study from different hospitals in tanzania.
A study from different hospitals in Tanzania.
Introduction: Under-reporting of adverse drug reactions is a major challenge in Tanzania. It is important to educate the health care providers about pharmacovigilance in order to improve the reporting rate.
Objectives: We conducted a study with the objective of evaluating the impact of an educational intervention based on the knowledge on pharmacovigilance among healthcare providers in Tanzania.
Methods: A pharmacovigilance e-blended learning method was used. Pre and post-test, courses were the basic concepts in Pharmacovigilance and the safety of Anti-Tuberculosis Drugs. Descriptive analyses were run to determine the proportions of the correct and wrong answers for pre and post training.
Results A total of 118 (72%) completed the pre-and post-test for both the first and the second courses. There was an increase in the correct answers in the post-test to every question. The median score of pre-intervention for knowledge about basic pharmacovigilance increased from 5 (range 4-7) in pre-test to 8 (range 7-9) in post-test. The median score for anti-TB drug safety issues monitoring and management increased from 4 (range 4-6) in pre-test to 7 (range 7-9) in post-test.
Conclusion: The findings of this study showed that knowledge scores and correct answers were increased following an educational intervention among HCP.
Abu Farha, R., Abu Hammour, K., Rizik, M., Aljanabi, R., & Alsakran, L. (2018). Effect of educational intervention on healthcare providers knowledge and perception towards pharmacovigilance: A tertiary teaching hospital experience. Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 26(5), 611–616.
Barry, A., Olsson, S., Minzi, O., Bienvenu, E., Makonnen, E., Kamuhabwa, A., Oluka, M., Guantai, A., Bergman, U., van Puijenbroek, E., Gurumurthy, P., & Aklillu, E. (2020). Comparative Assessment of the National Pharmacovigilance Systems in East Africa: Ethiopia, Kenya, Rwanda and Tanzania. Drug safety, 43(4), 339–350.
Barteit, S., Jahn, A., Banda, S. S., Bärnighausen, T., Bowa, A., Chileshe, G., Guzek, D., Jorge, M. M., Lüders, S., Malunga, G., & Neuhann, F. (2019). E-Learning for Medical Education in Sub-Saharan Africa and Low-Resource Settings: Viewpoint. Journal of medical Internet research, 21(1), e12449.
Isah, A. O., Pal, S. N., Olsson, S., Dodoo, A., & Bencheikh, R. S. (2012). Specific features of medicines safety and pharmacovigilance in Africa. Therapeutic advances in drug safety, 3(1), 25–34.
Karolinska Institutet S. (2018). Pharmacovigilance infrastructure and post-marketing surveillance system capacity building for regional medicine regulatory harmonization in East Africa (PROFORMA). 2018;(October):1-3. https://proforma.ki.se/
Khadem Broojerdi, A., Baran Sillo, H., Ostad Ali Dehaghi, R., Ward, M., Refaat, M., & Parry, J. (2020). The World Health Organization Global Benchmarking Tool an Instrument to Strengthen Medical Products Regulation and Promote Universal Health Coverage. Frontiers in medicine, 7, 457.
Makanjuola, V., Doku, V., Jenkins, R., & Gureje, O. (2012). Impact of a one-week intensive 'training of trainers' workshop for community health workers in south-west Nigeria. Mental health in family medicine, 9(1), 33–38.
Manyazewal, T., Marinucci, F., Belay, G., Tesfaye, A., Kebede, A., Tadesse, Y., Lehman, S., & Temesgen, Z. (2017). Implementation and Evaluation of a Blended Learning Course on Tuberculosis for Front-Line Health Care Professionals. American journal of clinical pathology, 147(3), 285–291.
Mormina, M., & Pinder, S. (2018). A conceptual framework for training of trainers (ToT) interventions in global health. Globalization and health, 14(1), 100.
Mukesh, D., Henry, K., Frasia, O.(2018). Investigation on the effect of a one-day pharmacovigilance training of healthcare professionals. Journal of Public Health and Epidemiology, 10(6):183-189.
Olsson, S., Pal, S. N., & Dodoo, A. (2015). Pharmacovigilance in resource-limited countries. Expert review of clinical pharmacology, 8(4), 449–460.
Olsson, S., Pal, S. N., Stergachis, A., & Couper, M. (2010). Pharmacovigilance activities in 55 low- and middle-income countries: a questionnaire-based analysis. Drug safety, 33(8), 689–703.
Shrestha, S., Sharma, S., Bhasima, R., Kunwor, P., Adhikari, B., & Sapkota, B. (2020). Impact of an educational intervention on pharmacovigilance knowledge and attitudes among health professionals in a Nepal cancer hospital. BMC medical education, 20(1), 179.
World Health Organization. (2019). Roadmap for access to medicines, vaccines and health product 2019-2023: comprehensive support for access to medicines, vaccines and other health products. World Health Organization.
Copyright (c) 2023 Eva Muro, Kilimanjaro Institute, Kissa Mwamwitwa, Seth Kisenge, Nellin Shiletiwa, Ugo Moretti, Riccardo Lora, Alberto Sabaini, Francesco Schievano, Mauro Venegoni, Mtani Njegere, Blandina Mmbaga, Adam Fimbo, Lara Magro
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.